Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Evangelia Ttofi has worked on the following 45 EPO patent applications which have been published in the last five years:

EP13152828

Preservation of bioactive materials by freeze dried foam

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/50
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION REFUSED
EP11769881

THERAPIES FOR IMPROVING PULMONARY FUNCTION

IPC classification:
A61K 39/395, A61P 37/08, C07K 16/24, G01N 33/577
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
The patent has been granted
EP11799104

ANTI-IL-18 ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/24
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13168817

Methods of treating systemic lupus erythematosus

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/24
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196199

Antibodies with decreased deamidation profiles

IPC classification:
A61K 9/00, A61K 39/395, A61K 47/02, A61K 47/12, A61K 47/18, A61K 47/26, C07K 16/24
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11842005

REGIMENS FOR TREATMENTS USING ANTI-IGF ANTIBODIES

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/22, C12P 21/08
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769477

FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS

IPC classification:
A61K 39/395, C07K 14/00, C07K 14/78, C07K 16/10, C07K 16/28, C07K 16/46, C07K 19/00
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12830128

METHODS FOR PROCESSING COAGULATION FACTORS

IPC classification:
C12P 21/02
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP12770487

TREATMENT FOR RHEUMATOID ARTHRITIS

IPC classification:
A61P 19/02, C07K 16/28
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP12848121

MULTISPECIFIC AND MULTIVALENT BINDING PROTEINS AND USES THEREOF

IPC classification:
A61K 39/00
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP12847479

COMBINATION THERAPIES USING ANTI- PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/00, C12P 21/08
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP12789521

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS, SCLERODERMA, AND MYOSITIS WITH AN ANTIBODY AGAINST INTERFERON-ALPHA

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28, C07K 16/42
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12785244

METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS

IPC classification:
G01N 33/569, G06F 19/00
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP12807214

METHODS FOR MAKING MULTIMERIC POLYPEPTIDES

IPC classification:
C07K 14/00, C07K 16/00, C07K 16/28, C07K 16/46
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11813105

METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCOJUGATES

IPC classification:
A61K 47/48, B01D 15/04, B01J 41/14, B01J 41/20, C07K 1/18, C07K 16/28
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP13772497

DEVICES HAVING THERMOCHROMIC RESPONSE INDICATORS

IPC classification:
A61J 1/18, A61M 5/50
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11835117

METHODS FOR PROCESSING INCLUSION BODIES

IPC classification:
C07K 1/113, C07K 1/34
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP13770070

TRANSMUCOSAL DELIVERY OF ENGINEERED POLYPEPTIDES

IPC classification:
A61K 38/16, A61K 38/17, A61P 17/00
Applicant:
AstraZeneca Pharmaceuticals LP
Agent:
Charlotte Teall, Forresters IP LLP
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14191479

Disease markers and uses thereof

IPC classification:
C12Q 1/68
Applicant:
MedImmune, LLC
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703012

PROCESS FOR REDUCING ANTIBODY AGGREGATE LEVELS AND ANTIBODIES PRODUCED THEREBY

IPC classification:
C07K 16/18
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP13803921

FIXED DOSAGE REGIMENS FOR ANTI-TYPE I INTERFERON RECEPTOR (IFNAR) ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/00, C07K 16/24
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP13787673

CTLA-4 VARIANTS

IPC classification:
A61K 38/16, C07K 1/00
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11769481

TRAIL R2-SPECIFIC MULTIMERIC SCAFFOLDS

IPC classification:
A61K 39/00, A61K 39/395, C07K 14/00, C07K 14/78, C07K 16/10, C07K 16/28, C07K 16/46, C07K 19/00
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11769752

COMPOSITIONS AND METHODS FOR TREATING COPD EXACERBATION

IPC classification:
A61K 38/00, A61K 39/395
Applicant:
MedImmune Limited
Applicant:
McMaster University
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13848584

STABLE, LOW VISCOSITY ANTIBODY FORMULATION

IPC classification:
A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Graham Matthew Lewis, J A Kemp
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP13854850

SWINE INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

IPC classification:
A61K 39/145
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13853844

METHODS OF TREATING S. AUREUS-ASSOCIATED DISEASES

IPC classification:
A61K 39/085
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14709713

PEGYLATED GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY

IPC classification:
A61K 47/48, C07K 14/605
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14776495

RECOMBINANT POLYPEPTIDE PRODUCTION

IPC classification:
C12N 5/07, C12N 5/16, C12P 19/34, C12P 21/06
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP11720265

DELIVERY OF CHOLESTERYL ESTER TO STEROIDOGENIC TISSUES

IPC classification:
A61K 38/45, A61P 1/16
Applicant:
MedImmune, LLC
Agent:
Garreth Andrew Duncan, D Young & Co LLP
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14797310

PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES

IPC classification:
C07K 1/22
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15176691

PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAME

IPC classification:
A61K 38/17, C07K 14/435
Agent:
Charlotte Teall, Forresters IP LLP
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14752848

GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETES

IPC classification:
C07K 14/575, C07K 14/605, C12N 15/62
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14835826

METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB

IPC classification:
A61K 39/00, A61K 39/395, G01N 33/48
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14761317

COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA

IPC classification:
A61K 35/76, C07K 14/535, C12N 15/86
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14777632

METHODS OF TREATING AND DIAGNOSING ALPHA-V-BETA-6 OVEREXPRESSING CANCER

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28, C07K 16/32
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14853201

METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMAB

IPC classification:
A61K 39/00, G01N 33/48
Applicant:
AstraZeneca AB
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14855343

STABLE, AQUEOUS ANTIBODY FORMULATIONS

IPC classification:
A61K 38/00, A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP15190653

METHODS OF REDUCING BASOPHIL LEVELS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
AstraZeneca AB
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP14870799

COMPOSITIONS AND METHODS FOR TREATING SARCOMA

IPC classification:
A61K 39/395, A61P 35/00
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15752581

ANTI-PCSK9~GLP-1 FUSIONS AND METHODS FOR USE

IPC classification:
A61K 38/26, A61P 3/10, C07K 16/40, C07K 16/46
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15799339

OX40L FUSION PROTEINS AND USES THEREOF

IPC classification:
A61K 39/00, C12P 21/08
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15832244

DETECTING RESIDUAL HOST CELL PROTEINS IN RECOMBINANT PROTEIN PREPARATIONS

IPC classification:
C40B 30/04
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15775130

1-ALKYL-6-OXO-1,6-DIHYDROPYRIDIN-3-YL COMPOUNDS AND USE AS SGRM MODULATORS

IPC classification:
A61K 31/4439, A61P 19/02, C07D 401/04
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
Request for examination was made
EP15777638

COMBINATION OF AN OMEGA-3 FATTY ACID AND AN SGLT-2 INHIBITOR FOR TREATING DISEASES OF THE LIVER

IPC classification:
A61K 31/202, A61K 31/7034, A61K 45/06, A61P 1/16, A61P 3/04, A61P 3/10
Applicant:
AstraZeneca AB
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
Request for examination was made

Please Sign in to use this feature